COMMUNIQUÉS West-GlobeNewswire
-
SK pharmteco annonce la certification CGMP de son site de production de vecteurs viraux à échelle commerciale en France
12/03/2026 -
Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement
12/03/2026 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
12/03/2026 -
Koelis annonce, à l’occasion du Congrès de l’EAU 2026, des innovations technologiques destinées à optimiser les flux de travail de biopsie par fusion IRM et à soutenir le développement de la thérapie focale dans la prise en charge du cancer de la prostate
12/03/2026 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2026
12/03/2026 -
Aeroflow Health Earns 2026 Great Place To Work Certification™
12/03/2026 -
Sanofi: Information concerning the total number of voting rights and shares - February 2026
12/03/2026 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
12/03/2026 -
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
12/03/2026 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 11 mars 2026
12/03/2026 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026
12/03/2026 -
HealthEx Partners with Microsoft to Bring Consumers’ Personal Health History to Copilot Health
12/03/2026 -
Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
12/03/2026 -
Serotonin Centers Introduces New Medical Longevity Model for the Fitness Industry
12/03/2026 -
Cloudcure Launches Companion App to Close Clinical Adherence Gap in Metabolic Health
12/03/2026 -
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
12/03/2026 -
Pelthos Therapeutics to Present at 38th Annual ROTH Conference
12/03/2026 -
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
12/03/2026 -
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
12/03/2026
Pages